As cancer rates rise due to lifestyle and pollution, the demand for nuclear isotopes in medical diagnostics is increasing. Many older reactors are being decommissioned, making these materials rarer. Bristol-based startup Astral Systems, leveraging multistate fusion technology, aims to address this with compact reactors that can be deployed in various settings. With significant investment secured, Astral's approach promises better efficiency and lower costs compared to traditional methods, and could also pave the way for applications in hybrid nuclear energy and space exploration.
The whole industry has been in sort of supply constraint historically because of this reliance on centralized reactors.
Whereas what we're proposing is placing them in industrial units or in the basement of hospitals or production centers.
Collection
[
|
...
]